MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

WAY-204688

CAS No. : 796854-35-8

MCE 站：WAY-204688

产品活性：WAY-204688 是雌激素受体 (ER-α) 选择性的，口服活性的 NF-κB 转录活性抑制剂。在 HAECT 细胞中，作用于NF-κB-Luc 荧光素酶，IC₅₀ 为 122?±?30 nM。

研究领域：NF-κB

作用靶点：NF-κB

In Vitro: WAY-204688 is ER-dependenrt (activity seen only when hER is coexpressed with NF-κB-luciferase in human aortic endothelial cell lines (HAECT-1) cells). The interaction of WAY-204688 with ERα and ERβ is examined in vitro. WAY-204688 displaces [³H]E2 from the ERα ligand binding domain protein (LBD) with IC₅₀=2.43 μM and from the ERβ ligand binding domain protein (LBD) with IC₅₀=1.5 μM.

In Vivo: WAY-204688 (5 mg/kg per day, po daily for 5 weeks) is evaluated in vivo for the ability to inhibit four proinflammatory genes (MHC, invariant chain (MHI), VCAM-1, RANTES, and TNF-α). The effect of WAY-204688 on induction of the gene products and on uterine wet weight is compared to that of 17α-ethinyl 17β-estradiol (EE at 10 μg/kg per day) in the same paradigm. Further characterization of WAY-204688 is carried out in several preclinical models of inflammatory disease. In the Lewis rat adjuvant-induced arthritis model (AIA), WAY-204688 is active at a dose of 0.3 mg/kg per day, po.

相关产品：Bortezomib  |  Pyrrolidinedithiocarbamate ammonium  |  JSH-23  |  Shikonin  |  Triptolide  |  Rocaglamide  |  Dihydroartemisinin  |  Baicalin  |  BAY 11-7085  |  Sulfasalazine  |  Betulinic acid  |  SN50  |  Parthenolide  |  (-)-DHMEQ  |  5-Aminosalicylic Acid  |  Caffeic acid phenethyl ester  |  Neferine  |  Tomatidine  |  QNZ  |  Withaferin A  |  Andrographolide  |  20(S)-Ginsenoside Rg3  |  Aristolochic acid A  |  B022  |  Maslinic acid  |  Ginsenoside Rb1  |  Lidocaine  |  Ethacrynic acid  |  Indole-3-carbinol  |  Mangiferin

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。